Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$41.99 USD
-0.53 (-1.25%)
Updated May 10, 2024 04:00 PM ET
After-Market: $42.00 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/29/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 0.00% |
ABR | 1.44 |
Earnings ESP
|
19.35% |
---|---|
Current Year | -1.14 |
Next Year | 1.09 |
EPS (TTM) | -3.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 190.36M | 214.27M | 807.83M | 1.17B |
# of Estimates | 8 | 8 | 8 | 7 |
High Estimate | 230.15M | 262.77M | 961.14M | 1.37B |
Low Estimate | 175.22M | 195.30M | 756.35M | 1.05B |
Year ago Sales | 94.97M | 110.40M | 396.59M | 807.83M |
Year over Year Growth Est. | 100.44% | 94.09% | 103.69% | 44.63% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.20 | -1.14 | 1.09 |
# of Estimates | 10 | 8 | 10 | 9 |
Most Recent Consensus | 0.26 | 0.41 | 1.14 | 2.47 |
High Estimate | 0.07 | 0.30 | 0.44 | 2.87 |
Low Estimate | -0.55 | -0.34 | -1.81 | 0.14 |
Year ago EPS | -1.02 | -1.17 | -4.45 | -1.14 |
Year over Year Growth Est. | 67.65% | 82.91% | 74.38% | 195.68% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 4 | 5 | 4 |
Up Last 30 Days | 3 | 4 | 4 | 4 |
Up Last 60 Days | 4 | 4 | 5 | 4 |
Down Last 7 Days | 1 | 1 | 1 | 2 |
Down Last 30 Days | 2 | 1 | 2 | 3 |
Down Last 60 Days | 3 | 3 | 3 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.33 | -0.20 | -1.14 | 1.09 |
7 Days Ago | -0.37 | -0.25 | -1.27 | 1.04 |
30 Days Ago | -0.39 | -0.28 | -1.36 | 1.04 |
60 Days Ago | -0.40 | -0.28 | -1.36 | 1.05 |
90 Days Ago | -0.31 | -0.19 | -1.14 | 1.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.13 | -0.90 | 1.16 |
Zacks Consensus Estimate | -0.33 | -0.20 | -1.14 | 1.09 |
Earnings ESP | 19.35% | 34.18% | 21.18% | 7.01% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.73 | -1.17 | -1.02 | NA |
Estimate | -0.54 | -0.66 | -0.84 | -1.35 | NA |
Difference | 0.00 | -0.07 | -0.33 | 0.33 | -0.02 |
Surprise | 0.00% | -10.61% | -39.29% | 24.44% | -6.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more